Evaluating the Cost for Robotic vs "Non-Robotic" Transhiatal Esophagectomy.


Journal

The American surgeon
ISSN: 1555-9823
Titre abrégé: Am Surg
Pays: United States
ID NLM: 0370522

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 20 11 2021
medline: 25 2 2022
entrez: 19 11 2021
Statut: ppublish

Résumé

This study was undertaken to analyze and compare the cost of robotic transhiatal esophagectomy (THE) to "non-robotic" THE (ie, "open" and laparoscopic). With IRB approval, we prospectively followed 82 patients who underwent THE. We analyzed clinical outcomes and perioperative charges and costs associated with THE. To compare profitability, the robotic approach was analyzed against "non-robotic" approaches of THE using F-test, Mann-Whitney U test/Student's t-test, and Fisher's exact test. Statistical significance was reported as 67 patients underwent the robotic approach, and 15 patients underwent "non-robotic" approach; 4 were "open" and 11 were laparoscopic. 79 patients had adenocarcinoma. Operative duration for robotic THE was 327 (331 ± 82.8) vs 213 (225 ± 62.0) minutes ( Patients were predominantly older overweight men who had adenocarcinoma of the esophagus. The robotic approach had increased operative time and minimal blood loss. More than a fourth of operations included concomitant procedures. Patients were discharged approximately one week after THE. Overall, the robotic approach has no apparent significant differences in charges, cost, or profitability.

Identifiants

pubmed: 34794333
doi: 10.1177/00031348211046885
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-393

Auteurs

Sharona B Ross (SB)

Digestive Health Institute, Tampa, FL, USA.

Shlomi Rayman (S)

Department of General Surgery, 64850Assuta Medical Center, Ashdod, Israel.
4422Affiliated to the Faculty of Health and Science, Ben-Gurion University, Beer-Sheba, Israel.

Ja'Karri Thomas (J)

Digestive Health Institute, Tampa, FL, USA.

George Peek (G)

Digestive Health Institute, Tampa, FL, USA.

Kaitlyn Crespo (K)

Digestive Health Institute, Tampa, FL, USA.

Cameron Syblis (C)

Digestive Health Institute, Tampa, FL, USA.

Iswanto Sucandy (I)

Digestive Health Institute, Tampa, FL, USA.

Alexander Rosemurgy (A)

Digestive Health Institute, Tampa, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH